tiprankstipranks
Unicycive Therapeutics (UNCY)
NASDAQ:UNCY
US Market
UNCY
Unicycive Therapeutics
RESEARCH TOOLSreports

Unicycive Therapeutics (UNCY) Financial Statements

839 Followers

Unicycive Therapeutics Financial Overview

Unicycive Therapeutics's market cap is currently $162.78M. The company's EPS TTM is $-0.32; its P/E ratio is -15.62; Unicycive Therapeutics is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Mar 23Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 675.00K$ 951.00K$ 0.00
Gross Profit$ 0.00$ 0.00$ 675.00K$ 951.00K$ 0.00
Operating Income$ -29.52M$ -32.12M$ -20.77M$ -18.05M$ -8.98M
EBITDA$ -25.91M$ -36.23M$ -30.18M$ -17.89M$ -9.38M
Net Income$ -26.55M$ -36.73M$ -30.54M$ -18.06M$ -10.02M
Balance Sheet
Cash & Short-Term Investments$ 41.27M$ 26.14M$ 9.70M$ 455.00K$ 16.58M
Total Assets$ 49.13M$ 31.67M$ 14.19M$ 2.82M$ 18.74M
Total Debt$ 117.00K$ 773.00K$ 811.00K$ 201.00K$ 335.00K
Net Debt$ -29.08M$ -25.37M$ -8.89M$ -254.00K$ -16.24M
Total Liabilities$ 18.94M$ 24.24M$ 18.00M$ 3.28M$ 2.26M
Stockholders' Equity$ 30.20M$ 7.43M$ -3.81M$ -466.00K$ 16.48M
Cash Flow
Free Cash Flow$ -31.34M$ -28.65M$ -18.30M$ -15.65M$ -5.80M
Operating Cash Flow$ -31.32M$ -28.57M$ -18.28M$ -15.65M$ -5.77M
Investing Cash Flow$ -12.10M$ -72.00K$ -12.00K$ -2.00K$ -29.00K
Financing Cash Flow$ 46.47M$ 45.09M$ 27.54M$ -471.00K$ 22.38M
Currency in USD

Unicycive Therapeutics Earnings and Revenue History

Income Statement >

Unicycive Therapeutics Debt to Assets

Balance Sheet >

Unicycive Therapeutics Cash Flow

Cash Flow >

Unicycive Therapeutics Forecast EPS vs Actual EPS

Earnings >